Depo-Provera (Medroxyprogesterone Acetate 150 mg/mL) is a long-acting injectable contraceptive that prevents pregnancy for up to 12 weeks per dose. It works by stopping ovulation and thickening cervical mucus. Ideal for women seeking hormone-based birth control without daily pills, itβs also used for endometriosis and hormone therapy. Buy Depo-Provera online from MedicarePharm for authentic Pfizer injections, medical guidance, and discreet worldwide delivery across the U.S., U.K., and Europe.
Product Description
π Depo-Provera β Long-Acting Injectable Birth Control for 3-Month Protection
πΈ Overview
Depo-Provera (Medroxyprogesterone Acetate) is a long-acting injectable contraceptive that provides effective pregnancy prevention for up to 12 weeks with a single injection. It is a progestin-only birth control method, making it ideal for women who cannot use estrogen-based contraceptives.
Originally developed by Upjohn Pharmacia and now manufactured by Pfizer Pharmaceuticals, Depo-Provera has been trusted worldwide for decades as a safe, reliable, and reversible contraceptive option. It also has additional clinical benefits in managing endometriosis and certain hormone-sensitive cancers.
At MedicarePharm, we offer authentic Pfizer Depo-Provera injections with discreet delivery and access to licensed medical support for women across the U.S., U.K., and Europe.
βοΈ Active Ingredient
Component
Strength
Function
Medroxyprogesterone Acetate (MPA)
150 mg/mL
A long-acting progestin that prevents ovulation and thickens cervical mucus to block sperm entry.
Depo-Provera works by releasing a steady, low dose of Medroxyprogesterone, a synthetic form of the natural hormone progesterone. It prevents pregnancy through three mechanisms:
1οΈβ£ Stops ovulation β prevents the ovaries from releasing eggs. 2οΈβ£ Thickens cervical mucus β makes it difficult for sperm to reach the egg. 3οΈβ£ Thins the uterine lining β reduces the likelihood of implantation.
π‘ With proper use, Depo-Provera is more than 99% effective, offering worry-free contraception for 12 weeks per injection.
π§ Dosage and Administration
Form: Sterile aqueous suspension in 1 mL vials (150 mg/mL).
Route:Deep intramuscular injection in the gluteal or deltoid muscle.
Given within the first 5 days of menstruation for immediate protection.
If postpartum and not breastfeeding, injection can be given 5 days after delivery.
If breastfeeding exclusively, begin 6 weeks postpartum after ruling out pregnancy.
π Repeat Injections:
Administered every 90 days, ideally not delayed beyond 13 weeks to maintain full contraceptive protection.
β οΈ Shake the vial well before use to ensure even suspension. Must be injected intramuscularly β not subcutaneously.
πΌ Therapeutic Uses
Birth Control: Provides 3-month pregnancy protection per injection.
Endometriosis: Reduces pain and tissue growth through hormone suppression.
Hormone Therapy: Used as palliative treatment in breast, endometrial, and renal cancers that are hormone-sensitive.
Menstrual Disorders: Helps reduce excessive bleeding or painful periods (amenorrhea common after continued use).
π Benefits of Depo-Provera
βοΈ Highly effective β less than 1 pregnancy per 100 women per year.
βοΈ Convenient β no daily pills or devices required.
βοΈ Safe while breastfeeding β does not affect milk quantity or infant health.
βοΈ Reduces risk of endometrial cancer for up to 8 years post-use.
βοΈ Helps manage endometriosis and menstrual pain.
βοΈ Ideal for women with sickle cell anemia due to reduced menstrual blood loss.
β οΈ Possible Side Effects
Common (mild and temporary):
Irregular or unpredictable bleeding (especially first months)
Headache, dizziness, or fatigue
Weight gain over time (average 2β6 kg within 1β4 years)
Mood changes or mild depression
Nausea, bloating, or abdominal discomfort
Breast tenderness or swelling
Less common:
Acne, hair loss, or excessive hair growth
Vaginal dryness or discharge
Joint or muscle pain
Serious (rare): π¨ Bone mineral density loss (reversible upon discontinuation) π¨ Blood clots, stroke, or hypertension π¨ Jaundice or liver dysfunction π¨ Allergic reaction or injection-site infection
π¬ Note: Prolonged use (over 2 years) may increase risk of bone loss; calcium and vitamin D supplements are recommended.
βοΈ Contraindications
Do not use Depo-Provera if you:
Are pregnant or suspect pregnancy
Have unexplained vaginal bleeding
Have or had breast cancer or any hormone-sensitive tumor
Have blood clotting disorders, stroke, or severe hypertension
Suffer from active liver disease or abnormal liver function
Are allergic to Medroxyprogesterone or formulation ingredients
π¬ Precautions
Use caution in patients with diabetes, osteoporosis, migraines, asthma, or heart/kidney disease.
Pap smear and blood pressure monitoring recommended before and during treatment.
Fluid retention may occur β especially in those prone to edema or heart conditions.
Pregnancy test required before initiation if menstrual irregularities occur.
π¬ Drug Interactions
Depo-Provera may alter laboratory test results, including:
Decreased plasma estrogen, progesterone, and cortisol levels
Altered glucose tolerance results
Changes in coagulation factor levels (II, VII, IX, X)
No major drug interactions reported with standard medications, but always inform your healthcare provider about ongoing treatments.
Long-term use may lower estrogen levels and reduce bone mineral density (BMD). Women under 25 or with osteoporosis risk factors should limit use to 2 years, unless benefits outweigh risks.
πΆ Return to Fertility
Fertility usually resumes within 11 months (range 9β12 months) after stopping Depo-Provera.
π€± Breastfeeding
Safe for use during lactation β minimal transfer to breast milk with no reported adverse infant effects.
π¬ Comprehensive contraceptive counseling and aftercare
At MedicarePharm, we ensure trusted reproductive healthcare for women who seek safe, effective, and long-lasting contraception options β delivered privately and professionally.